6American Academy of Pediatrics, Subcommittee on Diagnosis and Management of Bronchiolitis. Diagnosis and management of bronchiolitis[J], pediatrics,2006,118(4) : 1774-1793.
7Samarzija M, Jakopovic M, Pavicic F, et al. Montelukast in asthma treatment in Croatia [ J ].Coll Antropol, 2005,29 (2) : 683-688.
5Robertson C F, Price D, Henry R, et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am[J]. Respir Crit Care Med, 2007, 175: 323.
6Sigurs N, Bjamason R, Sigurbergsson F, et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at abe 7[J]. An J Respit Crit Care Med, 2000, 161(5): 1501.
7Bonville C A, Rosenberg H F, Domaehowske J B. Ribavifin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis[J]. Antiviral Research, 2005, 69: 53.
8Volovitz B, Weltiver Re, De Castro G, et al. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: rolein obstructive airway disease [J]. Pediatr Res, 1988, 24: 504.
9Bisgaa.rd H. Study group on montelukast in respiratory syncytial virus postbron-ehiolitis[J]. Am J Respir Crit Care Med, 2003, 167(3): 379.
10Arnirav M D. Real-Life Effectiveness of Singulair (Montelukast) in 506 Children with Mild to Moderate Asthma[J]. IMAI, 2008, 10: 287.
